硝普钠与酚妥拉明急诊治疗冠心病合并心力衰竭效果分析.docVIP

硝普钠与酚妥拉明急诊治疗冠心病合并心力衰竭效果分析 [摘要] 目的 探讨硝普钠与酚妥拉明急诊治疗冠心病合并心力衰竭效果。方法 整群选取于2014年8月―2015年12月在该院接受治疗的冠心病合并心力衰竭患者共86例，随机分为观察组和对照组。对照组采用甲磺酸酚妥拉明治疗，观察组采用硝普钠治疗。观察治疗效果及心功能指标。 结果 观察组治疗后，总有效率为88.4%，对照组为67.4%，观察组总有效率明显高于对照组，且观察组治疗后心功能指标LVEF、LVEDD以及LVESD均优于对照组，组间比较有差异（P 0.05）。结论 硝普钠治疗冠心病合并心力衰竭，能够改善患者的心力衰竭症状，提高临床治疗效果。 [关键词] 硝普钠；酚妥拉明；冠心病合并心力衰竭；效果 [中图分类号] R445 [文献标识码] A [文章编号] 1674-0742（2016）04（c）-0130-02 [Abstract] Objective To discuss the effect of sodium nitroprusside and phentolamine in emergency treatment of coronary heart disease combined with heart failure. Methods 86 cases of patients with coronary heart disease combined with heart failure treated in our hospital from August 2014 to December 2015 were selected and randomly divided into two groups， the control group were treated with phentolamine mesilate， the observation group were treated with sodium nitroprusside， and the treatment effects and heart function indexes were observed. Results After treatment， the total effective rate was 88.4% in the observation group and 67.4% in the control group， and the total effective rate in the observation group was obviously higher than that in the control group， and the heart function indexes including LVEF， LVEDD and LVESD after treatment in the observation group were better than those in the control group， and the comparisons between groups had differences， P 0.05. Conclusion Sodium nitroprusside in treatment of coronary heart disease combined with heart failure can improve the heart failure symptom of patients and improve the clinical treatment effect. [Key words] Sodium nitroprusside； Phentolamine； Coronary heart disease combined with heart failure； Effect 冠心病合并心力衰竭属于冠心病引发心功能不全的临床症候群，主要是由于患者的血液粘稠度增高、血流速度减慢，从而导致患者出现心肌缺血缺氧现象，促使体内大量的心肌细胞受到损伤，进而导致患者的心肌收缩能力降低，心排血量减少。该疾病具有较高的致死率，严重影响患者的生活质量。因此，如何有效控制患者病情的发展，降低致死率成为临床研究重点。此次研究整群选取于2014年8月―2015年12月在该院接受治疗的冠心病合并心力衰竭患者共86例作为研究对象，探讨硝普钠与酚妥拉明急诊治疗冠心病合并心力衰竭效果，现报道如下。 1 资料与方法 1.1 一般资料 整群选取于2014年8月―2015年12月在该院接受治疗的冠心病合并心力衰竭患者共86例，随机分为观察组和对照组，每组43例。所有患者均